Pembrolizumab/steroidsAutoimmune hepatitis, reactivation of hepatitis B and myopathy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1693卷 / 1期

关键词：

D O I：

10.1007/s40278-018-43301-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：411 / 411

相关论文

共 50 条

[21] RituximabFatal hepatitis B virus reactivation: case report
Reactions Weekly, 2006, 1085 (1) : 23 - 23
[22] RituximabFatal hepatitis B virus reactivation: case report
Reactions Weekly, 2011, 1339 (1) : 35 - 35
[23] ImatinibFatal hepatitis B virus reactivation: case report
Reactions Weekly, 2006, 1090 (1) : 15 - 15
[24] PembrolizumabChronic hepatitis-B reactivation: case report
Reactions Weekly, 2025, 2040 (1) : 811 - 811
[25] Everolimus/octreotideFulminant hepatitis B reactivation: case report
Reactions Weekly, 2021, 1875 (1) : 136 - 136
[26] AntineoplasticsFatal hepatitis B virus reactivation: case report
Reactions Weekly, 2011, 1350 (1) : 11 - 11
[27] AntineoplasticsLate reactivation of hepatitis-B: case report
Reactions Weekly, 2019, 1750 (1) : 41 - 41
[28] Octreotide/sirolimusFatal hepatitis B reactivation: case report
Reactions Weekly, 2015, 1581 (1) : 239 - 239
[29] AntiviralsFatal fulminant hepatitis B reactivation: case report
Reactions Weekly, 2020, 1803 (1) : 46 - 46
[30] Lamivudine withdrawalFatal hepatitis B reactivation: case report
Reactions Weekly, 2006, 1108 (1) : 14 - 14

← 1 2 3 4 5 →